[1] Eckmann DM. Polidocanol for endovenous microfoam sclerosant therapy[J]. Expert Opin Investig Drugs, 2009, 18(12): 1919-1927. [2] Wollmann JC. The history of sclerosing foams [J]. Dermatol Surg, 2004, 30(5): 694-703. [3] Parsi K, Exner T, Connor DE, et al. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro [J]. Eur J Vasc Endovasc Surg, 2008, 36(2): 216-223. [4] Goldman MP, Bergan JJ, Guex JJ. Sclerotherapy: treatment of varicose and telangiectatic leg veins [M]. 4th Ed. Philadelphia: Mosby Elsevier, 2007. [5] Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins [J]. Dermatol Surg, 2001, 27(1): 58-60. [6] Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results [J]. Dermatol Surg, 2003, 29(12): 1170-1175. [7] Alòs J, Carre?o P, López JA, et al. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial [J]. Eur J Vasc Endovasc Surg, 2006, 31(1): 101-107. [8] Gorriz-Gomez E, Vicente-Barrero M, Loras-Caballero ML, et al. Sclerotherapy of face and oral cavity low flow vascular malformations: our experience[J]. Br J Oral Maxillofac Surg, 2014, 52(1): 43-47. [9] Yamaki T, Sasaki Y, Hasegawa Y, et al. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations [J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5): 707-714. [10] Chen AW, Liu YR, Li K, et al. Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck [J]. Br J Oral Maxillofac Surg, 2015, 53(9): 809-813. [11] 刘莉, 刘冬晓, 赵吉宏, 等. 聚桂醇联合平阳霉素治疗 120 例静脉畸形疗效观察 [J]. 上海口腔医学, 2016, 25(5): 588-592. [12] 朱声荣, 汤国雄, 陶学金, 等. 聚桂醇注射液治疗口腔颌面部脉管性病变的临床观察 [J]. 临床口腔医学杂志, 2012, 28(2): 111-112. [13] Ergun O, Atli E, Gulek B, et al. Intraarterial polidocanol injection for the treatment of peripheral arteriovenous malformations [J]. Surg Today, 2014, 44(7): 1232-1241. [14] Grover C, Arora P, Kedar A, et al. Combination of oral corticosteroids and polidocanol sclerotherapy in the management of infantile hemangiomas[J]. Dermatol Surg, 2010, 36(12): 2030-2036. [15] Jia X, Mowatt G, Burr JM, et al. Systematic review of foam sclerotherapy for varicose veins[J]. Br J Surg, 2007, 94(8): 925-936. [16] Cavezzi A, Parsi K. Complications of foam sclerotherapy [J]. Phlebology, 2012, 27(Suppl 1): 46-51. [17] Allevi F, Rabbiosi D, Mandalà M, et al. Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation [J]. BMJ Case Rep, 2014, pii: bcr2014206781. [18] Malvehy MA, Asbjornsen C. Transient neurologic event following administration of foam sclerotherapy [J]. Phlebology, 2017, 32(1): 66-68. [19] Guex JJ, Allaert FA, Gillet JL, et al. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12173 sclerotherapy sessions [J]. Dermatol Surg, 2005, 31(2): 123-128. |